Coronary CT angiography has proven to be a boon to radiologists and cardiologists in private practice. With a high negative predictive value, it can easily rule out coronary artery disease in patients with nondiagnostic electrocardiograms. For cardiologists in particular, CTA can help offset declining reimbursements associated with catheter procedures and nuclear medicine tests. But some cardiologists resist.
Coronary CT angiography has proven to be a boon to radiologists and cardiologists in private practice. With a high negative predictive value, it can easily rule out coronary artery disease in patients with nondiagnostic electrocardiograms. For cardiologists in particular, CTA can help offset declining reimbursements associated with catheter procedures and nuclear medicine tests. But some cardiologists resist.
"The CT coronary angiogram is demonstrating its usefulness as a noninvasive alternative to conventional catheter angiography that is capable of documenting both hard- and soft-plaque formations. With recent emphasis being placed on data surrounding the study of soft-plaque formation and its relationship to acute myocardial infarction, it seems CT angiography will become an integral tool in the prevention and treatment of coronary artery disease and acute myocardial infarction.
"Not every cardiologist is ready to roll over for coronary CTA, however. The invasive cardiologists want to know how accurate it is. Additionally, they are concerned it will take some of their income away. We see that. We tell them that cardiac CT will actually help to increase invasive procedures. Even hospitals are concerned about the potential loss of money from fewer catheter procedures. They are resistant to adopting CTA.
"Nationally, the statistics show that almost half of all cardiac cath procedures are negative, meaning they do not result in stenting or bypass surgery. If you can evaluate patients noninvasively, you're saving thousands of dollars, as well as diminishing real but low risks of mortality and morbidity."
-Dr. Steven M. Strobbe, executive physician and CEO of Florida Institute for Advanced Diagnostic Imaging in Port Richey
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.